ArticleFrontiers in pharmacology2023

Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer.

Emily M J Fennell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.